Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 48, 1993 - Issue 3
15
Views
5
CrossRef citations to date
0
Altmetric
Original articles

Von Recklinghausen Neurofibromatosis and Hematologic Malignancies: 2 Case Reports in Adulthood.

, &
Pages 164-170 | Published online: 16 May 2016

References

  • Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981; 305: 1617–1627.
  • Mulvihill JJ. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Intern Med. 1990;113: 39–52.
  • Sørensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms. N Engl J Med. 1986; 314: 10101015.
  • Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr. 1978; 92:925–929.
  • Reich SD, Wiernik PH. Von Recklinghausen neurofibromatosis and acute leukemia. Am J Dis Child. 1976; 130: 888–889.
  • Goerg C, Goerg K, Pflueger KH, Havemann K. Neurofibromatosis and acute monocytic leukemia in adults. Cancer. 1989; 64: 1717–1719.
  • Roloff JS, Najjar JL, LukensJN.Erythroleukemia in an infant with neurofibromatosis. J Pediatr. 1978;93:888–889.
  • McWhirter WR, Savage DCL, Williams BM. Neurofibromatosis with leukemia. Br Med J. 1971; 4: 114–115.
  • Kaneko Y, Maseki N, Sakurai M et al. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis. Leukemia. 1989; 3: 36–41.
  • Matzke E, Winkler K, Grosch-Worner I et al. Beitrag zur juvenilen chronischen myeloischen Leukamie (JCML). Fallbschreibung und Verlaufsbeobachtungen bei 9 Patienten. Klin Pediatr. 1980; 192: 157.
  • Shannon K, Watterson J, Johnson P et al. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, Type 1: epidemiology and molecular analysis. Blood. 1992; 79: 13111318.
  • Schaison G, Weisgerber C, Seligmann M. Les leucemies myelomonocytaires avec xanthomes. Nouv Rev Fr Hematol. 1970; 10: 284’288.
  • Kelleher JF, CarboneTV. Monosomy 7 syndrome in an infant with neurofibromatosis. Am J Pediatr Hematol Oncol. 1991; 13: 338.
  • Germain D, Trouillas P, Robert JM. Leucemies de l’enfant et maladie de Recklinghausen (A propos de 5 observations dont 2 leucemies familiales). Nouv Rev Fr Hematol. 1972; 12:555–560.
  • Shannon K, Nunez G, Dow LW et al. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies. Pediatrics. 1986; 77: 330.
  • Mays J A, Neerhout RC, Bagby GC, Koler RD. Juvenile chronic granulocytic leukemia: emphasis on cutaneous manifestations and underlying neurofibromatosis. Am J Dis Child. 1980; 134(7): 654–658.
  • Hardisty R, Speed D, Till M. Granulocytic leukemia in childhood. Br J Haematol. 1964; 10: 551–566.
  • Arakawa S, Imashuku D, Todo S et al. Juvenile chronic myelocytic leukemia associated with neurofibromatosis and 45, XO karyotype. Rinsho Ketsueki. 1979; 20: 519.
  • PalmerCG, Provisor AJ, WeaverDD, Hodes ME, Heerema N. Juvenile chronic granulocytic leukemia in a patient with trisomy 8, neurofibromatosis and prolonged Epstein-Barr virus infection. J Pediatr. 1983; 102(6): 888–892.
  • Bestak M, Miller DR, Mouradian JS. Juvenile chronic myelogenous leukemia with dermal histiocytosis. Am J Dis Child. 1979; 133: 831.
  • Weiner MA, Harris MB, Siegel RB, Klein G. Ganglioneuromaand acute lymphoblastic leukemia in association with neurofibromatosis. Am J Dis Child. 1982; 136(2): 1090–1091.
  • Mc Evoy W, Mann JR. Neurofibromatosis with leukemia. Br Med J. 1971; 3: 641.
  • Cockington RA. Leukemic infiltration of the gastrointestinal tract. An unusual cause of proteinlosing enteropathy. Med J Aust. 1975; 1: 103.
  • Clark RD, Hutter JJ. Familial neurofibromatosis and juvenile chronic myelogenous leukemia. Human Genet. 1982; 60: 230–232.
  • Borocai EI, Pesselman DE, Korsunskaia SM Leukemia in neurofibromatosis patients. Vrach Delo. 1974; S:117–119.
  • Wallace M, Marchuk D, Andersen L et al. Type Neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249: 181–186.
  • Viskochil D, Buchberg A, Xu G et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990; 62: 187–192.
  • Cawthon R, Weiss R, Xu G et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990; 62: 193201.
  • Goldberg N, Collins F. The hunt for the neurofibromatosis gene. Arch Dermatol. 1991 127: 1705–1707.
  • Gutmann D, Wood D, Collins F. Identification of the neurofibromatosis type 1 gene product. ProC Natl Acad Sci. 1991; 88: 9658–62.
  • DeClue J, Cohen B, Lowy D. Identification and characterization of the neurofibromatosis type protein product. Proc Natl Acad Sci. 1991; 88: 9914–18.
  • Ledbetter D, Rich D, O’Connell P, Leppert M. Carey J. Precise localization of NF1 to 17q 11.2 by balanced translocation. Am J Hum Genet. 1989; 44: 20–24.
  • Martin G, Viskochil D, Bollag G et al. The GAP Related domain of the neurofibromatosis type gene product interacts with ras p21. Cell. 1990; 63: 843–849.
  • Bos J. Ras oncogenes in human cancer: a review. Cancer Res. 1989; 49: 4682–4689.
  • Weinberg R. Tumor suppressor genes. Science 1991;254:1138–1146.
  • Menon A, Anderson K, Riccardi V et al. Chromosome 17p deletions and p5 3 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen’s neurofibromatosis. Proc Natl Acad Sci. 1990; 87: 5435–5439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.